Clinical Trials
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 1–12 of 380 articles
Quick answer
NovaPharmaNews Clinical Trials hub for FDA covers 380 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
HFMA conference: Affordability was the focus, but fixes remained unclear
FDA Clears First OTC CGM for Children: Dexcom Expands Stelo
FDA authorizes generic nitenpyram for New World screwworm in pets
HHS responds coolly to alcohol risk paper amid cancer-warning debate
Sepsis AI algorithms need real-time data, not hindsight
Merck and Gilead report mixed outcomes in lung cancer and HIV studies
Nektar Therapeutics pipeline update: REZPEG, amphotericin B and UK site changes
Sanofi pipeline pdf: Dupixent, Lantus and 2026 catalysts
Cardiff Oncology pipeline update: onvansertib trials, FDA meeting, and catalysts
Alnylam pipeline update: AMVUTTRA catalysts, outlook and profitability
Neurocrine Biosciences pipeline update: what analysts should watch next
Arcus Biosciences pipeline update: casdatifan, quemliclustat, domvanalimab
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.